about
Micellar versus reversed phase liquid chromatography for the determination of desferrioxamine and its chelates with aluminium and iron in uremic serumProgression of secondary hyperparathyroidism involves deregulation of genes related to DNA and RNA stability.Identification, cloning and characterization of an aldo-keto reductase from Trypanosoma cruzi with quinone oxido-reductase activity.Aluminum exposure in chronic renal failure in iberoamerica at the end of the 1990s: overview and perspectives.Pathogenesis, prevention and management of low-bone turnover.Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.Falls explain between-center differences in the incidence of limb fracture across Europe.The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS.Osteoporosis in chronic kidney disease.Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk.What should the characteristics and attributes of an accredited nephrology training programme be? Looking for high standardsVascular calcifications: pathogenesis, management, and impact on clinical outcomes.Influence of body mass index on the association of weight changes with mortality in hemodialysis patientsA new role for vitamin D receptor activation in chronic kidney disease.Management of osteoporosis in the elderly.New therapies: calcimimetics, phosphate binders and vitamin D receptor activators.Estrogens and bone disease in chronic kidney disease: role of FGF23.Parathyroid gland regulation: contribution of the in vivo and in vitro models.The position of strontium ranelate in today's management of osteoporosis.Geographic and other determinants of BMD change in European men and women at the hip and spine. a population-based study from the Network in Europe for Male Osteoporosis (NEMO).Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease.Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.Role of iron metabolism in absorption and cellular uptake of aluminum.The hypercalcaemia of CYP24A1 inactivation: new ways to improve diagnosis and treatment.The connections between vascular calcification and bone health.Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression.Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population.Reconsidering the importance of long-term low-level aluminum exposure in renal failure patients.Effect of aluminium load on parathyroid hormone synthesis.Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells.The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study.Reference values for trace and ultratrace elements in human serum determined by double-focusing ICP-MS.Bone aluminum uptake in uremic rats receiving intraperitoneal iron.Nutritional status in dialysis patients: a European consensus.COSMOS: the dialysis scenario of CKD-MBD in Europe.Phosphorus and survival: key questions that need answers.Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation.Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS).
P50
Q28299115-31A8297C-AC1F-498C-8A40-18578E0FD697Q31171309-DC995D30-9FC6-4EDA-9092-A3BB1F4E4AADQ33623185-76C45642-3769-49FE-ADF7-0E7C8D8A405DQ34028889-C0AA5FD7-F4A4-4D83-95C8-7092FCFD9312Q34080041-B242B650-96F0-4A8D-A903-991B1C63664EQ34254721-7D6C9938-532F-4D7F-9B45-B2FE408B2E5BQ34617700-B8CCEADB-A574-42C7-8E8B-405939B690CDQ35047195-0C8650B4-F742-4AF5-B700-BDFD3953D97CQ35573642-DB29E372-9687-44F8-8B47-2900FD287C8EQ35674619-B70A9160-02BA-49F7-BF9C-5B725C4B9C94Q36009303-5A364E8D-9675-4380-A873-8037F079ED82Q36482953-BC6C7B27-06AB-4997-8B47-ED997B6AAA2EQ36665930-408C9116-9C8B-4127-A4CE-4CF3BE18051DQ37212390-086CAE0D-0532-4A33-A451-1F77166C898EQ37558961-997FEF76-5221-4322-ABC3-EC2624003AA1Q37570565-C030912F-44B8-4960-A1D2-53AEF079A996Q37691299-00755E76-795B-4CD0-BFDA-6DEB3B01CFC5Q37767123-9588B1F1-8511-474D-92D7-DA30B6659FC3Q38028534-CD542D3A-70C0-4332-9E69-60E19353BD1CQ38418620-0CA2B3D2-1EA6-4CB5-8C75-9F5E88D1D378Q38507656-85D26C8A-9E95-4916-8256-846AE07EF79CQ38567745-64844591-9137-4A54-A8E8-264228E4C955Q40436890-8627DAA5-0666-43EC-88F8-8AC485F8C8D1Q41688321-15562D9B-749B-488B-80EE-9788AF26E83BQ42392761-63D87A84-11C6-4EC9-A1E0-14C0FAC25B69Q42917000-58AA559D-8FC9-4319-8CA8-312456DEB553Q43102195-486BECAC-5BD5-444A-9372-97EBB7D8CB9DQ43272938-C152B04E-1703-4AA7-8701-F5E64FFEA63FQ43441543-B914D777-04C7-4987-8B26-57EFAAFCC162Q43530564-105B0648-4A00-4FC8-9598-6D8D9CC3887CQ43556762-E539BC70-FC6E-4F0F-9353-F6BE9879DFACQ43609842-90060C39-2BB1-41CC-A1C7-0ECDED339F3FQ43752974-82F5F9A1-221D-44E7-B0B0-F1F2DB777472Q43791629-B5899DE0-2979-4F60-89ED-4DCDBFABE1BEQ43870791-2415BAD1-E4AA-4ACC-9E64-9FE16622511EQ43935593-B433976C-EAD5-4B07-A85A-D9AFB0D2C7C8Q43939289-FAA9DF93-3DE1-4D5E-9E2E-66305921BD80Q44032043-DC4475E9-D494-4BDB-9973-B3728CE25E24Q44211594-5E2285B6-30BF-483D-BD03-5384FC6E6FC3Q44254602-B38FCD0B-DA63-406F-8993-82749BD0CD72
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jorge B Cannata-andía
@ast
Jorge B Cannata-andía
@en
Jorge B Cannata-andía
@es
Jorge B Cannata-andía
@nl
Jorge B Cannata-andía
@sl
type
label
Jorge B Cannata-andía
@ast
Jorge B Cannata-andía
@en
Jorge B Cannata-andía
@es
Jorge B Cannata-andía
@nl
Jorge B Cannata-andía
@sl
prefLabel
Jorge B Cannata-andía
@ast
Jorge B Cannata-andía
@en
Jorge B Cannata-andía
@es
Jorge B Cannata-andía
@nl
Jorge B Cannata-andía
@sl
P1053
L-2260-2013
P106
P21
P31
P3829
P496
0000-0001-6543-9960